Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies
Hanker, Ariella B., Pfefferle, Adam D., Balko, Justin M., Kuba, María Gabriela, Young, Christian D., Sánchez, Violeta, Sutton, Cammie R., Cheng, Hailing, Perou, Charles M., Zhao, Jean J., Cook, Rebecca S., Arteaga, Carlos L.
Published in Proceedings of the National Academy of Sciences - PNAS (27.08.2013)
Published in Proceedings of the National Academy of Sciences - PNAS (27.08.2013)
Get full text
Journal Article
Stand Up to Cancer Phase Ib Study of Pan-Phosphoinositide-3-Kinase Inhibitor Buparlisib With Letrozole in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
MAYER, Ingrid A, ABRAMSON, Vandana G, CANTLEY, Lewis C, WINER, Eric, ARTEAGA, Carlos L, ISAKOFF, Steven J, FORERO, Andres, BALKO, Justin M, KUBA, María Gabriela, SANDERS, Melinda E, YAP, Jeffrey T, VAN DEN ABBEELE, Annick D, YISHENG LI
Published in Journal of clinical oncology (20.04.2014)
Published in Journal of clinical oncology (20.04.2014)
Get full text
Journal Article
Trastuzumab-Resistant Cells Rely on a HER2-PI3K-FoxO-Survivin Axis and Are Sensitive to PI3K Inhibitors
CHAKRABARTY, Anindita, BHOLA, Neil E, SUTTON, Cammie, GHOSH, Ritwik, KUBA, Maria Gabriela, DAVE, Bhuvanesh, CHANG, Jenny C, ARTEAGA, Carlos L
Published in Cancer research (Chicago, Ill.) (01.02.2013)
Published in Cancer research (Chicago, Ill.) (01.02.2013)
Get full text
Journal Article
Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation
Fox, Emily M, Kuba, María Gabriela, Miller, Todd W, Davies, Barry R, Arteaga, Carlos L
Published in Breast cancer research : BCR (11.07.2013)
Published in Breast cancer research : BCR (11.07.2013)
Get full text
Journal Article
LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer
Schwarz, Luis J, Fox, Emily M, Balko, Justin M, Garrett, Joan T, Kuba, María Gabriela, Estrada, Mónica Valeria, González-Angulo, Ana María, Mills, Gordon B, Red-Brewer, Monica, Mayer, Ingrid A, Abramson, Vandana, Rizzo, Monica, Kelley, Mark C, Meszoely, Ingrid M, Arteaga, Carlos L
Published in The Journal of clinical investigation (01.12.2014)
Published in The Journal of clinical investigation (01.12.2014)
Get full text
Journal Article
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
Bhola, Neil E, Balko, Justin M, Dugger, Teresa C, Kuba, María Gabriela, Sánchez, Violeta, Sanders, Melinda, Stanford, Jamie, Cook, Rebecca S, Arteaga, Carlos L
Published in The Journal of clinical investigation (01.03.2013)
Published in The Journal of clinical investigation (01.03.2013)
Get full text
Journal Article
TGF-[Beta] Inhibition enhances chemotherapy action against triple-negative breast cancer
Bhola, Neil E, Balko, Justin M, Dugger, Teresa C, Kuba, María Gabriela, Sánchez, Violeta, Sanders, Melinda, Stanford, Jamie, Cook, Rebecca S, Arteaga, Carlos L
Published in The Journal of clinical investigation (01.03.2013)
Get full text
Published in The Journal of clinical investigation (01.03.2013)
Journal Article
The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation‐associated angiosarcomas of the breast
Kuba, Maria Gabriela, Xu, Bin, D’Angelo, Sandra P, Rosenbaum, Evan, Plitas, George, Ross, Dara S, Brogi, Edi, Antonescu, Cristina R
Published in Histopathology (01.11.2021)
Published in Histopathology (01.11.2021)
Get full text
Journal Article
Clinicopathologic and molecular correlates to neoadjuvant chemotherapy‐induced pathologic response in breast angiosarcoma
Chang, Hsin‐Yi, Dermawan, Josephine K., Kuba, Maria Gabriela, Crago, Aimee M., Singer, Samuel, Tap, William, Chi, Ping, D'Angelo, Sandra, Rosenbaum, Evan, Antonescu, Cristina R.
Published in Genes chromosomes & cancer (01.05.2024)
Published in Genes chromosomes & cancer (01.05.2024)
Get full text
Journal Article
A gene expression signature of MEK pathway activation to predict survival in triple-negative breast cancer
Balko, Justin M., Sanders, Melinda, Kuba, Maria Gabriela, Pinto, Joseph A., Doimi, Franco F., Gomez, Henry Leonidas, Arteaga, Carlos L.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Clinical and pathologic characteristics of patients with PI3K-mutant breast cancers
Lloyd, M. Cooper, Sanders, Melinda, Kuba, Maria Gabriela, Farley, Jaime, Lai, Darson, Su, Zengliu, Mayer, Ingrid A., Means-Powell, Julie Ann, Vnenzak-Jones, Cindy, Levy, Mia Alyce, Pao, William, Arteaga, Carlos L., Abramson, Vandana Gupta
Published in Journal of clinical oncology (10.09.2013)
Published in Journal of clinical oncology (10.09.2013)
Get full text
Journal Article
Abstract A007: Mutant PIK3CA accelerates HER2-driven transgenic mammary tumor progression, enhances cancer stem cell features, and induces resistance to combinations of anti-HER2 therapies
Hanker, Ariella B., Pfefferle, Adam, Balko, Justin M., Kuba, Maria Gabriela, Young, Christian D., Sanchez, Violeta, Sutton, Cammie R., Cheng, Hailing, Perou, Charles M., Zhao, Jean J., Cook, Rebecca S., Arteaga, Carlos L.
Published in Molecular cancer research (01.10.2013)
Published in Molecular cancer research (01.10.2013)
Get full text
Journal Article
SU2C phase Ib study of pan-PI3K inhibitor BKM120 with letrozole in ER+/HER2- metastatic breast cancer (MBC)
Mayer, Ingrid A., Abramson, Vandana Gupta, Balko, Justin M., Isakoff, Steven J., Kuba, Maria Gabriela, Sanders, Melinda, Forero-Torres, Andres, Yap, Jeffrey T., Van Den Abbeele, Annick D., Li, Yisheng, Arteaga, Carlos L., Winer, Eric P.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article